参考文献/References:
[1] 潘国刚, 杨碧秀. 鼻咽癌不同临床分期中白细胞介素水平表达的最新研究进展[J]. 现代检验医学杂志,2021, 36(5): 184-188. PAN Guogang, YANG Bixiu. Latest research progress on the expression mechanism of interleukin in nasopharyngeal carcinoma different clinical staging[J]. Journal of Modern Laboratory Medicine, 2021, 36(5): 184-188.
[2] LUAN Weihong, YUAN Haozhan, HOU Wei, et al. Improvement and prognosis analysis of nimotuzumab combined with TP regimen induction chemotherapy and sequential concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma[J].American Journal of Translational Research, 2022,14(8): 5630-5640.
[3] TANG Linglong, GUO Rui, ZHANG Ning, et al. Effect of radiotherapy alone vs radiotherapy with concurrent chemoradiotherapy on survival without disease relapse in patients with low-risk nasopharyngeal carcinoma:a randomized clinical trial[J]. Journal of the American Medical Association, 2022, 328(8): 728-736.
[4] HUANG Bo, LI Yiliang, DENG Zhuoxia, et al. Regulatory mechanism of LncRNA CTBP1-AS2 in nasopharyngeal carcinoma cell proliferation and apoptosis via the miR-140-5p/BMP2 axis[J]. Protein and Peptide Letters, 2022, 29(7): 621-630.
[5] YOU Rui, ZOU Xiong, WANG Shunlan, et al. New surgical staging system for patients with recurrent nasopharyngeal carcinoma based on the AJCC/UICC rTNM classification system[J]. European Journal of Cancer, 2015, 51(13): 1771-1779.
[6] EISENHAUER E A, THERASSE P, BOGAERTS J, et al. New response evaluation criteria in solid tumours:revised RECIST guideline (version 1.1)[J]. European Journal of Cancer, 2009, 45(2): 228-247.
[7] ZHONG Guihua, WEI Wei, LIAO Wei, et al. Tumor microbiome in nasopharyngeal carcinoma and its association with prognosis[J]. Frontiers in Oncology,2022, 12: 859721.
[8] 薛玉峰, 张会平, 王芳, 等. 鼻咽癌患者血清miR-144-3p 及miR-151-3p 的表达水平及临床价值[J]. 现代检验医学杂志, 2021, 36(5): 65-68. XUE Yufeng, ZHANG Huiping, WANG Fang, et al. Expression and clinical value of serum miR-144-3p and miR-151-3p levels in patients with nasopharyngeal carcinoma[J]. Journal of Modern Laboratory Medicine,2021, 36(5): 65-68.
[9] AI Q H, HUNG K F, SO T Y, et al. Prognostic value of cervical nodal necrosis on staging imaging of nasopharyngeal carcinoma in era of intensity-modulated radiotherapy: a systematic review and meta-analysis[J].Cancer Imaging, 2022, 22(1): 24.
[10] NG W T, CHOW J C H, BEITLER J J, et al. Current radiotherapy considerations for nasopharyngeal carcinoma[J]. Cancers, 2022, 14(23): 5773.
[11] WANG Haihua, WANG Weiyuan, FAN Songqing. Emerging roles of LncRNA in nasopharyngeal carcinoma and therapeutic opportunit ies [ J ] . International Journal of Biological Sciences, 2022,18(7): 2714-2728.
[12] GUO Zhen, WANG Youhong, XU Heng, et al. LncRNA linc00312 suppresses radiotherapy resistance by targeting DNA-PKcs and impairing DNA damage repair in nasopharyngeal carcinoma[J]. Cell Death & Disease, 2021, 12(1): 69.
[13] WANG Weifeng, ZHANG Zhuo, LI Yundong, et al. Down-regulated long non-coding RNA LHFPL3 antisense RNA 1 inhibits the radiotherapy resistance of nasopharyngeal carcinoma via modulating microRNA-143-5p/homeobox A6 axis[J]. Bioengineered, 2022,13(3): 5421-5433.
[14] LI Yongfeng, ZONG Jin, ZHAO Cong. LncRNA CTBP1-AS2 promotes proliferation and migration of glioma by modulating miR-370-3p-Wnt7a-mediated epithelial-mesenchymal transition[J]. Biochemistry and Cell Biology, 2020, 98(6): 661-668.
[15] LIU Lixia, LIU Bin, YU Jie, et al. SP1-induced upregulation of LncRNA CTBP1-AS2 accelerates the hepatocellular carcinoma tumorigenesis through targeting CEP55 via sponging miR-195-5p[J]. Biochemical and Biophysical Research Communications, 2020, 533(4):779-785.
[16] LE T A H, LAO T D. Circulating microRNAs as the potential diagnostic and prognostic biomarkers for nasopharyngeal carcinoma[J]. Genes, 2022, 13(7):1160.
[17] TIAN Yutong, TANG Lu, YI Pin, et al. MiRNAs in radiotherapy resistance of nasopharyngeal carcinoma[J].Journal of Cancer, 2020, 11(13): 3976-3985.
[18] SONG Qingxu, CHEN Pengxiang, CHEN Xin, et al. Dynamic change of amide proton transfer imaging in irradiated nasopharyngeal carcinoma and related histopathological mechanism[J]. Molecular Imaging and Biology, 2021, 23(6): 846-853.
[19] 叶裕丰, 许宗为, 曾伟华, 等. 酰胺质子转移成像技术在鼻咽癌放化疗后疗效预测的价值[J]. 磁共振成像, 2020, 11(8) :635-640. YE Yufeng, XU Zongwei, ZENG Weihua, et al. The value of amide proton transfer imaging in predicting the effect of nasopharyngeal carcinoma after chemoradiotherapy[J]. Chinese Journal of Magnetic Resonance Imaging, 2020, 11(8): 635-640.
相似文献/References:
[1]李 璐,梁 辉a,陈群蓉b.鼻咽癌组织中SYK基因启动子区的甲基化分析[J].现代检验医学杂志,2015,30(02):39.[doi:10.3969/j.issn.1671-7414.2015.02.012]
LI Lu,LIANG Huia,CHEN Qun-rongb.Methylation of SYK Gene Promoter Region in Nasopharyngeal Carcinoma[J].Journal of Modern Laboratory Medicine,2015,30(02):39.[doi:10.3969/j.issn.1671-7414.2015.02.012]
[2]彭玉凤,张扬南,黄常洪,等.鼻咽癌患者血清同型半胱氨酸水平与临床病理特征的相关性分析[J].现代检验医学杂志,2019,34(02):115.[doi:10.3969/j.issn.1671-7414.2019.02.029]
PENG Yu-feng,ZHANG Yang-nan,HUANG Chang-hong,et al.Correlation Analysis between Serum Homocysteine Level ofNasopharyngeal Carcinoma Patients and Clinical Pathological Features[J].Journal of Modern Laboratory Medicine,2019,34(02):115.[doi:10.3969/j.issn.1671-7414.2019.02.029]
[3]张玲,刘杰,王臣玉,等.EB 病毒Rta 优势表位抗原的克隆表达及在应用ELISA 诊断鼻咽癌中的价值[J].现代检验医学杂志,2020,35(05):1.[doi:10.3969/j.issn.1671-7414.2020.05.001]
ZHANG Ling,LIU Jie,WANG Chen-yu,et al.Cloning and Expression of Dominant Epitope Antigen of Epstein-Barr
Virus Rta Protein and Its Application in the Diagnosis of Nasopharyngeal
Carcinoma by ELISA[J].Journal of Modern Laboratory Medicine,2020,35(02):1.[doi:10.3969/j.issn.1671-7414.2020.05.001]
[4]薛玉峰a,张会平a,王 芳b,等.鼻咽癌患者血清miR-144-3p及miR-151-3p的表达水平及临床价值[J].现代检验医学杂志,2021,36(05):65.[doi:10.3969/j.issn.1671-7414.2021.05.015]
XUE Yu-fenga,ZHANG Hui-pinga,WANG Fangb,et al.Expression and Clinical Value of Serum miR-144-3p and miR-151-3pLevels in Patients with Nasopharyngeal Carcinoma[J].Journal of Modern Laboratory Medicine,2021,36(02):65.[doi:10.3969/j.issn.1671-7414.2021.05.015]
[5]潘国刚,杨碧秀.鼻咽癌不同临床分期中白细胞介素水平表达的最新研究进展[J].现代检验医学杂志,2021,36(05):184.[doi:10.3969/j.issn.1671-7414.2021.05.040]
PAN Guo-gang,YANG Bi-xiu.Latest Research Progress on the Expression Mechanism of Interleukin inNasopharyngeal Carcinoma Different Clinical Staging[J].Journal of Modern Laboratory Medicine,2021,36(02):184.[doi:10.3969/j.issn.1671-7414.2021.05.040]
[6]胡鹏刚,张昌明.枸杞皂苷通过调控Suv39H1/JAK2/STAT3通路对鼻咽癌细胞增殖、侵袭和凋亡的影响[J].现代检验医学杂志,2021,36(06):27.[doi:10.3969/j.issn.1671-7414.2021.06.006]
HU Peng-gang,ZHANG Chang-ming.Lycium Barbarum Saponins Affect Proliferation, Invasion and Apoptosis of Nasopharyngeal Carcinoma Cells by Regulating the Suv39H1/JAK2/STAT3 Pathway[J].Journal of Modern Laboratory Medicine,2021,36(02):27.[doi:10.3969/j.issn.1671-7414.2021.06.006]